The fourth component of IRT is Redox Regulatory Therapy, which selectively targets tumor sites with intense levels of oxidative stress. This means that the therapy is designed to attack tumor cells only and present no harm to healthy tissue. The combination of high-dose intravenous vitamin C therapy, coupled with ozone autohemotherapy and the oxygen-carrier Perftec, achieves this desirable effect. The result is a therapy that can often effectively hold tumor growth at bay while augmenting the killing effect of concurrent cytotoxic therapy.
The first component of IRT is Oxidative Preconditioning Therapy. Oxidants are substances in our body that can damage our cells.
Integrative Regulatory Therapy, or IRT, is the integration of therapies that have a powerful synergistic effect upon each other.
The second component of IRT is Cytotoxic Therapy. For years, we have been able to use high dose intravenous vitamin C as a powerful and natural cytotoxic agent.
The third component of IRT is Cell Signal Transduction Therapy, which uses nutraceuticals (pharmaceutical-grade vitamin supplements with medicinal qualities) and “safe” (nontoxic) drugs to target particular cell signaling pathways in cancer cells.